Search for: "Tom Lamb"
Results 1 - 20
of 1,040
Sort by Relevance
|
Sort by Date
3 Jan 2025, 2:35 pm
" (Posted by Tom Lamb at Drug Injury Watch) In our November 21, 2024 article, "Do Andexxa Risks Outweigh Benefits Given Increased Rate of Thrombosis and Thrombosis-Related Deaths? [read post]
18 Dec 2024, 2:03 pm
European Drug Regulators Investigating Semaglutide-Related NAION Cases Presented in Two Danish Studies (Posted by Tom Lamb at Drug Injury Watch) According to this December 18, 2024, Reuters news report, "Novo Nordisk's Ozempic faces EU review for potential eye disease connection", there is a significant development concerning semaglutide weight-loss drugs like Ozempic linked to vision loss and blindness: The European Union's drug… [read post]
12 Dec 2024, 3:05 pm
New Cases of Liver Transplants And Liver-Related Deaths Among Patients Who Did Not Have Cirrhosis (Posted by Tom Lamb at Drug Injury Watch) In a December 12, 2024, Drug Safety Communication the FDA said it had recently found cases of Ocaliva liver injury among patients who did not yet have cirrhosis, or scarring of the liver, including reports of liver transplants and liver-related deaths. [read post]
Do Andexxa Risks Outweigh Benefits Given Increased Rate of Thrombosis and Thrombosis-Related Deaths?
21 Nov 2024, 12:00 pm
Issue to be Considered by FDA Advisory Committee on November 21, 2024, and Discussion May Lead to Andexxa Drug Recall (Posted by Tom Lamb at Drug Injury Watch) At its November 21, 2024 meeting, the FDA's Cellular, Tissue, and Gene Therapies Advisory Committee will discuss whether Andexxa risks outweigh benefits. [read post]
28 Oct 2024, 1:41 pm
Accidents can happen anytime and anywhere, and New York City is no exception. [read post]
16 Oct 2024, 1:44 pm
Intracranial Meningioma Risks Are Increased When Depo-Provera Was Used for More Than One Year (Posted by Tom Lamb at Drug Injury Watch) A medical journal article published in March 2024 reported that Depo-Provera (medroxyprogesterone acetate) increased the risk of intracranial meningioma by 5.6 times if Depo-Provera was used as birth control for longer than a year. [read post]
30 Sep 2024, 11:02 am
Federal Appeals Court Rejects Merck's Legal Defense of Federal Preemption in September 2024 (Posted by Tom Lamb at Drug Injury Watch) A federal appeals court ruled in September 2024 that more than 500 plaintiffs should have their Fosamax femur fracture drug injury lawsuits reinstated and sent back to the current judge presiding over the federal court Fosamax MDL litigation. [read post]
12 Sep 2024, 1:40 pm
August 2024 Veozah Drug Label Change Adds Warnings About Liver Toxicity and Abnormal Liver Tests (Posted by Tom Lamb at Drug Injury Watch) On September 12, 2024, the FDA announced a warning about the rare occurrence of serious liver injury when a woman is using Veozah for hot flashes due to menopause. [read post]
26 Aug 2024, 9:15 am
Drug Company Apellis Failed to Warn About Retinal Vasculitis Until a November 2023 Label Change (Posted by Tom Lamb at Drug Injury Watch) We are handling Syfovre injections side effects legal compensation cases being filed for patients The basis for these product liability personal injury lawsuits is the drug company Apellis failed to warn about retinal vasculitis until a November 2023 label change. [read post]
18 Jul 2024, 12:53 pm
Growing Number of Pulmonary Embolism and DVT Cases Involving Semaglutide Reported by Patients (Posted by Tom Lamb at Drug Injury Watch) Wegovy, Rybelsus, and Ozempic have been associated with an increased risk of blood clots that can lead to pulmonary embolism (sometimes called PE) and deep vein thrombosis (often called DVT). [read post]
5 Jul 2024, 9:30 am
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), or "Eye Stroke", Can Cause Vision Loss (Posted by Tom Lamb at Drug Injury Watch) Wegovy, Rybelsus, and Ozempic eye side effects are possible given the recent finding that the active ingredient of these three drugs semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION). [read post]
28 Jun 2024, 11:45 am
EMA’s CHMP Does Not Approve Syfovre for a Second Time, Citing "significant risk of adverse events" (Posted by Tom Lamb at Drug Injury Watch) There seems to be some disagreement about the Syfovre safety-benefit assessment when it comes to the US FDA and its European counterpart, the European Medicines Agency (EMA). [read post]
14 May 2024, 2:07 pm
Semaglutide-related Side Effects Include Ischemic Stroke, Pulmonary Embolism, and Deep Vein Thrombosis (Posted by Tom Lamb at Drug Injury Watch) Wegovy, Rybelsus, and Ozempic are drugs with semaglutide as their active ingredient. [read post]
24 Apr 2024, 11:30 am
She Went to the Local ER With Loss of Vision 11 Days After Receiving an Intravitreal Syfovre (Pegcetacoplan) Injection (Posted by Tom Lamb at Drug Injury Watch) In the March 2024 edition of the American Journal of Ophthalmology Case Reports medical journal, there is a Syfovre retinal vaso-occlusive vasculitis case report involving a 78-year old woman with vision loss that happened back in the first part of 2023. [read post]
24 Apr 2024, 5:57 am
This autocracy threat tracker is also available as a PDF file. [read post]
4 Apr 2024, 11:52 am
Retinal Vasculitis After Syfovre Injections: Etiology is Still Unknown and Incidence Rate Remains Unclear (Posted by Tom Lamb at Drug Injury Watch) Syfovre (pegcetacoplan) was approved by the FDA in February 2023 as an eye injection to treat geographic atrophy (GA), a relatively rare condition secondary to age-related macular degeneration. [read post]
8 Mar 2024, 3:00 am
National/Federal Nikki Haley Suspends Her Campaign and Leaves Donald Trump as the Last Major Republican Candidate Associated Press News – Steve Peoples and Meg Kinnard | Published: 3/6/2024 Nikki Haley suspended her presidential campaign after being soundly defeated across the country on Super Tuesday, leaving Donald Trump as the last remaining major candidate for the 2024 Republican nomination. [read post]
6 Mar 2024, 12:10 pm
Pre-Existing Allergy Toward Polyethylene Glycol (PEG) is Most Recent Causation Theory Offered by Apellis (Posted by Tom Lamb at Drug Injury Watch) In late January 2024, a leading medical journal for ophthalmologists and retina specialists, the Journal of VitreoRetinal Diseases, published this Syfovre case report, "Occlusive Retinal Vasculitis After a Single Injection of Pegcetacoplan", written by three authors affiliated with the Department of… [read post]
22 Feb 2024, 10:10 am
Research Finding: Semaglutide Increased the Risk of Deep Vein Thrombosis (DVT) by 266% in Patients with Type 2 Diabetes (Posted by Tom Lamb at Drug Injury Watch) Semaglutide-containing drugs that are being used for weight loss purposes include Ozempic, Rybelsus, and Wegovy. [read post]
9 Feb 2024, 12:03 pm
Learn About Related Symptoms and Diagnosis Process for Gastroparesis, a Side Effect of Ozempic, Wegovy, Rybelsus, and Trulicity (Posted by Tom Lamb at Drug Injury Watch) In this article, we present some gastroparesis case reports involving the use of GLP-1 receptor agonists semaglutide (e.g., Ozempic, Wegovy, Rybelsus) or dulaglutide (e.g., Trulicity) that have been published recently by medical journals. [read post]
